On October 7th, the Nobel Committee announced that Drs. Victor Ambrose and Gary Ruvkun were awarded the 2024 Nobel Prize in Physiology and Medicine. Ambros | Immunology ...

Longeveron (NASDAQ: LGVN) , a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, will be represented at ...

A research team led by Associate Professor Hidetoshi Sakurai and Researcher Nana Takenaka-Ninagawa recently demonstrated the ...

As the travel industry struggles to reduce its environmental impact, here's how cruise lines are working towards sustainable ...

To register for the event, please contact your UBS representative. The Longeveron investor presentation is available at the “Events & Presentations” section of the Company’s website. About Longeveron ...

NDAQ:BCLI) BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare ...

A cross-disciplinary team, led by the University of Glasgow, alongside the Universities of Nottingham and Strathclyde, will use pioneering technology ...

A cross-disciplinary team, led by the University of Glasgow, will use pioneering technology to manufacture human stem cells ...